Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target

Using a Muc6 knockout mouse model, gastric organoids, and cell lines, the authors proposed that golgi stress responses and aberrant glycans induced by mucin deletion were important drivers of gastric cancer.